From: Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications
Intervention (PAC) | Anticoagulation | Non-anticoagulation | p-value |
---|---|---|---|
Number | 44 | 35 | |
PAC treatment: (At initial presentation) | |||
Low dose LMWH, n (%)a | 15 (34) | – | – |
High dose LMWH, n (%)b | 7 (16) | – | – |
Warfarin with LMWH bridging, n (%)c | 16 (36) | – | – |
Warfarin without bridging, n (%) | 6 (13) | ||
Anti-platelet treatmentd, n (%) | 4 (9) | 7 (20) | 0.20 |